← Research index  ·  Disorder page  ·  Source YAML

Cross-provider research synthesis

Beta-Ketothiolase Deficiency

MONDO:0008760 Curated 2026-07-04T00:00:00Z 9 harmonized findings
falcon · 20 citations openscientist · 21 citations
Concordant asserts the finding Partial supports a weaker/qualified form Contradictory conflicts with it Silent does not address it

Harmonized findings

Beta-ketothiolase deficiency is a rare autosomal recessive inborn error of metabolism caused by biallelic ACAT1 variants that reduce mitochondrial acetoacetyl-CoA thiolase (T2), an enzyme acting at the intersection of isoleucine catabolism and ketone body metabolism (ketolysis).

UNANIMOUS INTEGRATED
ProviderStanceScoreEvidence
falcon CONCORDANT 95% Beta-ketothiolase deficiency (BKD) is a rare autosomal recessive condition affecting isoleucine catabolism and ketone body metabolism.
Falcon states the autosomal recessive ACAT1/T2 basis and the dual isoleucine- catabolism / ketone-metabolism role directly.
DOI:10.1186/s40842-024-00174-9, DOI:10.25259/jped_9_2023
openscientist CONCORDANT 97% The disease results from deficiency of the mitochondrial enzyme acetoacetyl-CoA thiolase (T2), which catalyzes the thiolytic cleavage of 2-methylacetoacetyl-CoA (in isoleucine degradation) and acetoacetyl-CoA (in ketolysis).
OpenScientist gives the precise enzymatic reactions blocked in each of the two pathways, matching the mechanism Falcon summarizes.
PMID:32345314

The clinical hallmark is episodic ketoacidotic crises, typically in infancy or early childhood, precipitated by catabolic stressors such as intercurrent infection, fasting, or a ketogenic/high-protein diet, with relative wellness between episodes.

UNANIMOUS INTEGRATED
ProviderStanceScoreEvidence
falcon CONCORDANT 90% usually triggered by infection, prolonged fasting, or consumption of a ketogenic diet.
Falcon names the recurrent ketoacidosis phenotype and the same catabolic triggers (infection, fasting, ketogenic diet).
DOI:10.1186/s40842-024-00174-9
openscientist CONCORDANT 92% The hallmark of the disease is episodic ketoacidotic crisis, often precipitated by intercurrent illness, fasting, or metabolic stress
OpenScientist matches the episodic-crisis phenotype and the illness/fasting/ metabolic-stress triggers.
PMID:32345314

Diagnosis rests on characteristic urinary organic acids (2-methyl-3- hydroxybutyrate, tiglylglycine, and unstable 2-methylacetoacetate) and blood acylcarnitines (C5:1, C5-OH/C4OH), but the classic biochemical triad is not universally present and mild/residual-activity cases can be missed.

UNANIMOUS INTEGRATED
ProviderStanceScoreEvidence
falcon CONCORDANT 85% 2M3HB elevated in 23/26, TIG 13/26, and 2MAA 6/26, with the classic triad not universal.
Falcon reports the characteristic urinary metabolites and quantifies that the classic triad is not universal in a clinical cohort.
DOI:10.52852/tcncyh.v171i10.2016
openscientist CONCORDANT 85% Elevated urinary 2-methyl-3-hydroxybutyrate and tiglylglycine (present in virtually all patients)
OpenScientist lists the same diagnostic metabolites; it frames 2M3HB and tiglylglycine as near-universal, a mild quantitative divergence from Falcon's cohort figures.
PMID:20157782

Genotype does not correlate with the clinical phenotype but does shape the biochemical phenotype, reflecting variable residual T2 activity — with implications for newborn screening and disease management.

MAJORITY INTEGRATED
ProviderStanceScoreEvidence
openscientist CONCORDANT 95% the genotype does not correlate with the clinical phenotype but exerts a considerable effect on the biochemical phenotype
OpenScientist asserts the genotype-clinical dissociation with genotype- biochemical correlation, quoting Fukao et al.
PMID:31268215
falcon PARTIAL 50% residual T2 function is associated with milder/less distinctive biochemical abnormalities
Falcon supports the genotype-to-biochemical-phenotype link (residual activity to milder biochemistry) but does not state the explicit genotype-clinical dissociation.
DOI:10.52852/tcncyh.v171i10.2016

BKD is exceptionally rare, but reported incidence varies markedly by population and cohort, from roughly 1 per 1,000,000 in large Chinese newborn screening data to higher rates in specific ethnic/consanguineous subgroups.

UNANIMOUS INTEGRATED
ProviderStanceScoreEvidence
openscientist CONCORDANT 85% The disease is exceptionally rare, with an estimated incidence of approximately 1 per 1,000,000 newborns based on large-scale newborn screening data from China.
OpenScientist gives the headline ~1:1,000,000 Chinese NBS incidence plus regional estimates (Zhejiang, Egypt).
PMID:34001203
falcon CONCORDANT 60% BKD incidence was reported as 1:32,237 in this cohort (detected only in Miao subgroup).
Falcon reports a much higher cohort-specific rate (1:32,237, Miao subgroup), concordant on rarity and population dependence but quantitatively divergent from OpenScientist's broad estimate.
DOI:10.3389/fgene.2024.1387423

Overall prognosis is relatively favorable for an organic aciduria — most patients achieve normal psychomotor development with management, and crisis frequency tends to decline with age.

MAJORITY INTEGRATED
ProviderStanceScoreEvidence
openscientist CONCORDANT 90% 77% of patients demonstrate normal psychomotor development with appropriate management
OpenScientist quantifies the favorable outcome (77% normal psychomotor development) from the largest systematic review.
PMID:32345314
falcon PARTIAL 50% episodes tend to reduce in frequency with age and are reported as rare after age 10 in classic descriptions.
Falcon supports the natural-history improvement (fewer crises with age) but does not report the favorable-outcome statistics.

Severe or repeated crises can cause neurological injury; the characteristic pattern is a metabolic-stroke-type basal ganglia insult producing extrapyramidal sequelae, alongside acute encephalopathic features (seizures, coma) during decompensation.

MAJORITY INTEGRATED
ProviderStanceScoreEvidence
openscientist CONCORDANT 90% Acute energy failure in metabolically active brain regions (basal ganglia) during severe ketoacidosis
OpenScientist specifies the metabolic-stroke / basal-ganglia mechanism of neurological injury, backed by imaging and autopsy findings.
PMID:28726122
falcon PARTIAL 55% Seizures, coma, shock may occur in severe pediatric presentations, consistent with metabolic encephalopathy/critical illness physiology.
Falcon notes acute encephalopathic manifestations of severe crises but does not resolve the specific basal-ganglia / metabolic-stroke pattern.
DOI:10.25259/jped_9_2023

Management is dietary and supportive rather than curative: avoidance of fasting, mild protein/isoleucine restriction, L-carnitine supplementation, and sick-day protocols with IV dextrose to suppress ketogenesis during crises.

UNANIMOUS INTEGRATED
ProviderStanceScoreEvidence
falcon CONCORDANT 85% Avoid fasting; ensure regular carbohydrate intake; avoid ketogenic diets.
Falcon gives the chronic-prevention pillars (fasting avoidance, regular carbohydrate) and elsewhere IV dextrose and carnitine.
DOI:10.1186/s40842-024-00174-9
openscientist CONCORDANT 90% Mild protein restriction + L-carnitine supplementation + avoidance of fasting + sick-day education
OpenScientist itemizes the same maintenance strategy (protein restriction, L-carnitine, fasting avoidance, sick-day education).

BKD crises can be mistaken for diabetic ketoacidosis; blood glucose is characteristically normal (hypoglycemia is notably absent), though rare adult cases with coexisting diabetes and hyperglycemia have been reported.

UNANIMOUS LEAD
ProviderStanceScoreEvidence
openscientist CONCORDANT 80% Hypoglycemia is notably absent in BKTD, distinguishing it from many other organic acidemias
OpenScientist frames normal glucose (hypoglycemia absent) as a distinguishing feature from other organic acidemias and from DKA.
PMID:7726385
falcon CONCORDANT 70% episodes may mimic diabetic ketoacidosis with hyperglycemia
Falcon emphasizes the DKA-mimicry angle and the first adult BKD case with established diabetes and hyperglycemia — a different emphasis than OpenScientist's normal-glucose framing, but not a contradiction.
DOI:10.1186/s40842-024-00174-9
The adult diabetes / DKA-mimicry edge cases are retained as a research lead rather than promoted, consistent with the prior curation decision.

Narrative

Overview

Both providers characterize beta-ketothiolase deficiency (BKD / T2 deficiency) as a rare autosomal recessive ACAT1 disorder in which loss of mitochondrial acetoacetyl-CoA thiolase blocks both the terminal step of isoleucine catabolism and ketolysis, producing episodic ketoacidotic crises under catabolic stress. Falcon is narrowly pathophysiology-focused (2023-2024 literature, biochemistry, crisis physiology); OpenScientist is a broad 15-section disease characterization (genetics, epidemiology, prognosis, diagnostics, treatment, models).

Agreement

The reports converge on the core molecular defect, the dual-pathway enzyme role, the episodic-crisis phenotype with infection/fasting/diet triggers, the characteristic urinary organic acids and acylcarnitines (with the caveat that the triad is not universal and 2-methylacetoacetate is unstable), the genotype-to-biochemical-phenotype relationship, a generally favorable prognosis, and dietary/supportive management (fasting avoidance, protein restriction, L-carnitine, sick-day IV dextrose).

Divergence

OpenScientist adds quantitative and mechanistic depth Falcon lacks: the explicit genotype-clinical dissociation (Fukao), outcome statistics (77% normal development, 89.6% with crises), the metabolic-stroke / basal-ganglia injury mechanism, the ACAT1 variant spectrum and structural mapping, consanguinity/founder effects, and animal/in-vitro models. The two most notable divergences are quantitative or emphatic rather than contradictory: incidence (Falcon's cohort-specific 1:32,237 in a Miao subgroup vs OpenScientist's broad ~1:1,000,000), and glucose handling (Falcon foregrounds DKA-mimicry and a rare adult with coexisting diabetes/hyperglycemia, whereas OpenScientist stresses that glucose is typically normal and hypoglycemia is absent).

Integration

The core ACAT1/T2 defect, impaired isoleucine catabolism and ketolysis, the episodic-decompensation cascade, the characteristic biomarkers (2M3HB, tiglylglycine, 2MAA, C5:1, C5-OH), the neurological sequelae, and the dietary/carnitine/dextrose/sick-day management model are supported by both providers and belong in the disorder YAML. The genotype-phenotype dissociation and favorable-prognosis statistics are OpenScientist-led but well founded.

Not integrated (leads)

Variant-by-variant ACAT1 structural interpretation, the adult diabetic- ketoacidosis and DKA-mimicry edge cases, detailed newborn-screening operational metrics, and broad model-system / gene-therapy proposals are retained as research leads rather than promoted to curated disease mechanisms.

Cross-provider synthesis comparing falcon (pathophysiology-focused, DOI-based citations) and openscientist (comprehensive, PMID-based). No direct contradictions were found; divergence is coverage/recency plus two quantitative or emphatic differences (population incidence; glucose framing). All best_matching_text values are verbatim excerpts from the cited report files; literature evidence snippets are intentionally left to the main curation pipeline on the disorder YAML.